Trends in Dispensing of Zolpidem and Low-Dose Trazodone Among Commercially Insured Adults in the United States, 2011-2018-Reference-Cited by-同舟云学术

Trends in Dispensing of Zolpidem and Low-Dose Trazodone Among Commercially Insured Adults in the United States, 2011-2018

Published:2020-12-01 Issue:21 Volume:324 Page:2211
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Wong Jenna¹,Murray Horwitz Mara²,Bertisch Suzanne M.³,Herzig Shoshana J.⁴,Buysse Daniel J.⁵,Toh Sengwee¹

Affiliation:

1. Department of Population Medicine, Harvard Medical School, Boston, Massachusetts

2. Department of Medicine, Boston Medical Center, Boston, Massachusetts

3. Division of Sleep and Circadian Disorders, Brigham and Women’s Hospital, Boston, Massachusetts

4. Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts

5. Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2773553/jama_wong_2020_ld_200103_1606767629.07975.pdf

Reference6 articles.

1. Trends in insomnia and excessive daytime sleepiness among US adults from 2002 to 2012.;Ford;Sleep Med,2015

2. National use of prescription medications for insomnia: NHANES 1999-2010.;Bertisch;Sleep,2014

3. Ten-year trends in the pharmacological treatment of insomnia.;Walsh;Sleep,1999

4. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline.;Sateia;J Clin Sleep Med,2017

5. US Food and Drug Administration. FDA drug safety communication: FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR. Published May 14, 2013. Accessed June 30, 2020. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-approves-new-label-changes-and-dosing-zolpidem-products-and

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic burden of comorbid insomnia in 5 common medical disease subgroups;Journal of Clinical Sleep Medicine;2023-07

2. Anxiolytic-like effects of the dual orexin receptor antagonist daridorexant in rats;2023-06-26

3. Benzodiazepine Usage, Healthcare Resource Utilization, and Costs Among Older Adults Treated with Common Insomnia Medications: A Retrospective Cohort Study;ClinicoEconomics and Outcomes Research;2023-06

4. Investigating the effectiveness of electronically delivered cognitive behavioural therapy (e-CBTi) compared to pharmaceutical interventions in treating insomnia: Protocol for a randomized controlled trial;PLOS ONE;2023-05-16

5. Should Trazodone Be First-Line Therapy for Insomnia? A Clinical Suitability Appraisal;Journal of Clinical Medicine;2023-04-18